Concepts (258)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Erythrocytes | 25 | 2023 | 2415 | 4.420 |
Why?
|
Erythrocyte Indices | 4 | 2020 | 145 | 2.230 |
Why?
|
Anemia, Sickle Cell | 15 | 2023 | 1056 | 1.810 |
Why?
|
Hemoglobin, Sickle | 5 | 2023 | 113 | 1.800 |
Why?
|
Hemoglobins | 8 | 2019 | 1521 | 1.370 |
Why?
|
Oxygen | 9 | 2022 | 4193 | 1.030 |
Why?
|
Blood Cell Count | 4 | 2020 | 398 | 0.970 |
Why?
|
Hydroxyurea | 2 | 2023 | 283 | 0.930 |
Why?
|
Erythrocytes, Abnormal | 5 | 2023 | 121 | 0.860 |
Why?
|
Anemia, Iron-Deficiency | 2 | 2019 | 368 | 0.840 |
Why?
|
Erythrocyte Count | 3 | 2019 | 157 | 0.730 |
Why?
|
Furaldehyde | 1 | 2019 | 5 | 0.710 |
Why?
|
Blood Glucose | 5 | 2024 | 6379 | 0.690 |
Why?
|
Sickle Cell Trait | 2 | 2019 | 85 | 0.690 |
Why?
|
Isoantibodies | 2 | 2017 | 661 | 0.680 |
Why?
|
Hemorheology | 2 | 2016 | 144 | 0.620 |
Why?
|
Erythrocyte Volume | 2 | 2015 | 28 | 0.620 |
Why?
|
Microfluidic Analytical Techniques | 5 | 2022 | 806 | 0.580 |
Why?
|
Microfluidics | 4 | 2023 | 652 | 0.570 |
Why?
|
Postpartum Period | 2 | 2021 | 1168 | 0.560 |
Why?
|
Ferritins | 1 | 2019 | 598 | 0.560 |
Why?
|
Models, Biological | 7 | 2016 | 9468 | 0.540 |
Why?
|
Computational Biology | 4 | 2020 | 3505 | 0.530 |
Why?
|
Blood Viscosity | 5 | 2022 | 124 | 0.500 |
Why?
|
High-Throughput Screening Assays | 2 | 2019 | 944 | 0.470 |
Why?
|
Disease | 1 | 2020 | 671 | 0.470 |
Why?
|
Models, Statistical | 2 | 2019 | 5075 | 0.460 |
Why?
|
Homeostasis | 3 | 2019 | 3306 | 0.420 |
Why?
|
Pregnancy Complications, Hematologic | 1 | 2014 | 177 | 0.400 |
Why?
|
Monocytes | 2 | 2017 | 2575 | 0.360 |
Why?
|
Lymphocytes | 1 | 2017 | 2611 | 0.340 |
Why?
|
Kinetics | 6 | 2021 | 6377 | 0.340 |
Why?
|
Diabetes Mellitus | 2 | 2019 | 5890 | 0.330 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2024 | 3454 | 0.330 |
Why?
|
Blood Glucose Self-Monitoring | 3 | 2024 | 457 | 0.320 |
Why?
|
Glucose | 1 | 2021 | 4350 | 0.320 |
Why?
|
Models, Theoretical | 1 | 2020 | 3562 | 0.300 |
Why?
|
Hemorrhage | 1 | 2019 | 3599 | 0.290 |
Why?
|
Hematopoiesis | 4 | 2022 | 2063 | 0.280 |
Why?
|
Stochastic Processes | 1 | 2008 | 354 | 0.280 |
Why?
|
Single-Cell Analysis | 4 | 2019 | 2380 | 0.260 |
Why?
|
Rheology | 3 | 2022 | 348 | 0.250 |
Why?
|
Neutrophils | 1 | 2017 | 3767 | 0.240 |
Why?
|
Flow Cytometry | 2 | 2015 | 5869 | 0.230 |
Why?
|
Biomedical Research | 1 | 2020 | 3426 | 0.230 |
Why?
|
Acute Coronary Syndrome | 1 | 2017 | 2365 | 0.230 |
Why?
|
Humans | 54 | 2024 | 760613 | 0.210 |
Why?
|
Fetal Hemoglobin | 2 | 2023 | 342 | 0.210 |
Why?
|
Monensin | 1 | 2022 | 30 | 0.210 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3085 | 0.210 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3205 | 0.210 |
Why?
|
Ionophores | 1 | 2022 | 107 | 0.200 |
Why?
|
Antisickling Agents | 3 | 2021 | 72 | 0.200 |
Why?
|
Hospitalization | 2 | 2020 | 10789 | 0.200 |
Why?
|
Anemia | 1 | 2010 | 1511 | 0.190 |
Why?
|
Glucose Tolerance Test | 2 | 2021 | 1174 | 0.180 |
Why?
|
Physiological Phenomena | 1 | 2020 | 18 | 0.170 |
Why?
|
Acetylcholine | 1 | 2022 | 629 | 0.170 |
Why?
|
Clinical Chemistry Tests | 1 | 2020 | 59 | 0.170 |
Why?
|
Platelet Count | 1 | 2022 | 777 | 0.170 |
Why?
|
Anterior Wall Myocardial Infarction | 1 | 2020 | 43 | 0.170 |
Why?
|
Image Processing, Computer-Assisted | 2 | 2023 | 8950 | 0.170 |
Why?
|
Hematologic Diseases | 1 | 2023 | 497 | 0.170 |
Why?
|
Severe Acute Respiratory Syndrome | 1 | 2020 | 137 | 0.170 |
Why?
|
Carbohydrate Metabolism | 1 | 2020 | 262 | 0.160 |
Why?
|
Cell Biology | 1 | 2020 | 90 | 0.160 |
Why?
|
Giant Cell Arteritis | 1 | 2023 | 296 | 0.160 |
Why?
|
Hematology | 1 | 2022 | 241 | 0.160 |
Why?
|
Leukocyte Count | 1 | 2022 | 1599 | 0.150 |
Why?
|
Spleen | 2 | 2023 | 2298 | 0.150 |
Why?
|
Coronavirus | 1 | 2020 | 149 | 0.150 |
Why?
|
Viscosity | 4 | 2022 | 335 | 0.140 |
Why?
|
Reference Standards | 1 | 2020 | 1004 | 0.130 |
Why?
|
Fetus | 1 | 2023 | 1859 | 0.130 |
Why?
|
Dimethylpolysiloxanes | 1 | 2016 | 142 | 0.130 |
Why?
|
Adult | 11 | 2024 | 220007 | 0.130 |
Why?
|
Electric Conductivity | 1 | 2016 | 410 | 0.130 |
Why?
|
Lab-On-A-Chip Devices | 2 | 2018 | 432 | 0.130 |
Why?
|
Anemia, Macrocytic | 1 | 2015 | 54 | 0.130 |
Why?
|
Cell Size | 2 | 2014 | 624 | 0.120 |
Why?
|
Cytoplasmic Vesicles | 1 | 2014 | 73 | 0.120 |
Why?
|
Retrospective Studies | 6 | 2024 | 80345 | 0.120 |
Why?
|
Leukocytes | 1 | 2022 | 2027 | 0.120 |
Why?
|
Statistics, Nonparametric | 1 | 2020 | 2852 | 0.120 |
Why?
|
Anemia, Hemolytic, Congenital | 1 | 2014 | 71 | 0.120 |
Why?
|
Cardiovascular Diseases | 2 | 2022 | 15760 | 0.110 |
Why?
|
Glucuronosyltransferase | 1 | 2014 | 130 | 0.110 |
Why?
|
Hydrops Fetalis | 1 | 2014 | 109 | 0.110 |
Why?
|
Equipment Design | 3 | 2018 | 3520 | 0.110 |
Why?
|
Blood Flow Velocity | 3 | 2018 | 1377 | 0.110 |
Why?
|
Glucocorticoids | 1 | 2023 | 2145 | 0.110 |
Why?
|
Patient Admission | 1 | 2020 | 1385 | 0.110 |
Why?
|
Reference Values | 1 | 2020 | 4925 | 0.100 |
Why?
|
Hematocrit | 1 | 2014 | 629 | 0.100 |
Why?
|
Erythrocyte Transfusion | 1 | 2017 | 566 | 0.100 |
Why?
|
Predictive Value of Tests | 3 | 2020 | 15286 | 0.100 |
Why?
|
Blood | 1 | 2014 | 586 | 0.100 |
Why?
|
Cytochromes b | 1 | 2011 | 34 | 0.100 |
Why?
|
Hematopoiesis, Extramedullary | 1 | 2012 | 53 | 0.100 |
Why?
|
Blood Vessels | 1 | 2017 | 1112 | 0.100 |
Why?
|
Erythropoiesis | 1 | 2015 | 682 | 0.090 |
Why?
|
Pathology, Clinical | 1 | 2014 | 375 | 0.090 |
Why?
|
Optics and Photonics | 1 | 2012 | 305 | 0.090 |
Why?
|
Prognosis | 5 | 2023 | 29661 | 0.090 |
Why?
|
Risk Assessment | 4 | 2022 | 24102 | 0.090 |
Why?
|
Evolution, Molecular | 3 | 2011 | 1885 | 0.090 |
Why?
|
Scattering, Radiation | 1 | 2012 | 488 | 0.090 |
Why?
|
Female | 12 | 2021 | 391246 | 0.090 |
Why?
|
Host-Parasite Interactions | 1 | 2011 | 301 | 0.080 |
Why?
|
Proportional Hazards Models | 3 | 2020 | 12531 | 0.080 |
Why?
|
Ion Channels | 1 | 2014 | 1043 | 0.080 |
Why?
|
Suspensions | 1 | 2009 | 66 | 0.080 |
Why?
|
Erythrocyte Aggregation | 1 | 2009 | 35 | 0.080 |
Why?
|
Male | 11 | 2020 | 359718 | 0.080 |
Why?
|
Propranolol | 1 | 2010 | 489 | 0.080 |
Why?
|
Computer Simulation | 3 | 2020 | 6218 | 0.080 |
Why?
|
Models, Structural | 1 | 2008 | 341 | 0.080 |
Why?
|
Malaria | 2 | 2011 | 1226 | 0.080 |
Why?
|
Pregnancy | 3 | 2021 | 29746 | 0.070 |
Why?
|
Histocompatibility Antigens Class I | 1 | 2014 | 1355 | 0.070 |
Why?
|
Cell Shape | 2 | 2023 | 372 | 0.070 |
Why?
|
Middle Aged | 8 | 2020 | 220359 | 0.070 |
Why?
|
Boston | 1 | 2020 | 9278 | 0.070 |
Why?
|
Macaca mulatta | 1 | 2014 | 2316 | 0.070 |
Why?
|
Thrombocytopenia | 1 | 2015 | 1174 | 0.070 |
Why?
|
Cell Count | 1 | 2011 | 1835 | 0.070 |
Why?
|
Terminology as Topic | 1 | 2014 | 1535 | 0.070 |
Why?
|
Water | 1 | 2013 | 1407 | 0.070 |
Why?
|
Hospitals | 1 | 2020 | 3928 | 0.070 |
Why?
|
Hypoglycemic Agents | 1 | 2019 | 3149 | 0.070 |
Why?
|
Mitochondrial Proteins | 1 | 2011 | 979 | 0.060 |
Why?
|
Reproducibility of Results | 2 | 2023 | 20080 | 0.060 |
Why?
|
Mutation | 5 | 2022 | 29957 | 0.060 |
Why?
|
Muscular Diseases | 1 | 2010 | 551 | 0.060 |
Why?
|
Age Factors | 2 | 2019 | 18413 | 0.060 |
Why?
|
Motion | 1 | 2009 | 779 | 0.060 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2014 | 2829 | 0.060 |
Why?
|
Animals | 11 | 2022 | 167960 | 0.060 |
Why?
|
Inflammation | 2 | 2022 | 10755 | 0.060 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2010 | 1259 | 0.060 |
Why?
|
Transcription Factors | 1 | 2023 | 12102 | 0.060 |
Why?
|
Plasmodium falciparum | 2 | 2011 | 1742 | 0.060 |
Why?
|
Vascular Diseases | 1 | 2012 | 1181 | 0.050 |
Why?
|
RNA | 1 | 2013 | 2723 | 0.050 |
Why?
|
Aged, 80 and over | 5 | 2020 | 58980 | 0.050 |
Why?
|
Hematologic Neoplasms | 1 | 2014 | 1901 | 0.050 |
Why?
|
Prevalence | 1 | 2019 | 15686 | 0.050 |
Why?
|
Adolescent | 3 | 2019 | 87809 | 0.050 |
Why?
|
Disease Models, Animal | 2 | 2020 | 18137 | 0.050 |
Why?
|
Blood Transfusion | 3 | 2016 | 1328 | 0.050 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2019 | 10343 | 0.050 |
Why?
|
Friction | 1 | 2022 | 59 | 0.050 |
Why?
|
Hematopoietic Stem Cells | 1 | 2014 | 3390 | 0.050 |
Why?
|
Lipids | 1 | 2013 | 3336 | 0.050 |
Why?
|
Macrophages | 2 | 2020 | 5745 | 0.050 |
Why?
|
Cholinergic Agents | 1 | 2022 | 96 | 0.050 |
Why?
|
Aged | 6 | 2020 | 169143 | 0.050 |
Why?
|
Artificial Intelligence | 2 | 2022 | 2557 | 0.050 |
Why?
|
Aminopeptidases | 1 | 2021 | 95 | 0.050 |
Why?
|
Disease Progression | 1 | 2017 | 13505 | 0.040 |
Why?
|
Polymerization | 1 | 2021 | 157 | 0.040 |
Why?
|
Pandemics | 1 | 2020 | 8623 | 0.040 |
Why?
|
Parabiosis | 1 | 2020 | 64 | 0.040 |
Why?
|
Case-Control Studies | 1 | 2017 | 22052 | 0.040 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2015 | 3610 | 0.040 |
Why?
|
DNA | 1 | 2013 | 7233 | 0.040 |
Why?
|
Genome, Human | 2 | 2002 | 4418 | 0.040 |
Why?
|
Metalloendopeptidases | 1 | 2021 | 393 | 0.040 |
Why?
|
Data Interpretation, Statistical | 1 | 2009 | 2696 | 0.040 |
Why?
|
Time Factors | 3 | 2017 | 40139 | 0.040 |
Why?
|
Leukocytosis | 1 | 2020 | 251 | 0.040 |
Why?
|
Stem Cell Niche | 1 | 2022 | 346 | 0.040 |
Why?
|
Exchange Transfusion, Whole Blood | 1 | 2018 | 59 | 0.040 |
Why?
|
Plant Extracts | 1 | 2022 | 496 | 0.040 |
Why?
|
Risk Factors | 6 | 2022 | 74333 | 0.040 |
Why?
|
Proteins | 1 | 2013 | 6029 | 0.040 |
Why?
|
Prednisone | 1 | 2023 | 1566 | 0.040 |
Why?
|
Shear Strength | 1 | 2018 | 161 | 0.040 |
Why?
|
Selection, Genetic | 1 | 2002 | 870 | 0.040 |
Why?
|
Heart Failure | 1 | 2022 | 11848 | 0.040 |
Why?
|
Recombination, Genetic | 1 | 2002 | 1526 | 0.040 |
Why?
|
Membrane Proteins | 1 | 2014 | 7850 | 0.040 |
Why?
|
Microscopy, Interference | 1 | 2016 | 35 | 0.030 |
Why?
|
Erythrocyte Deformability | 1 | 2016 | 55 | 0.030 |
Why?
|
Haplotypes | 1 | 2002 | 2764 | 0.030 |
Why?
|
Glucose Intolerance | 1 | 2020 | 580 | 0.030 |
Why?
|
Young Adult | 3 | 2017 | 58748 | 0.030 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2019 | 12289 | 0.030 |
Why?
|
Osmotic Fragility | 1 | 2014 | 36 | 0.030 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2010 | 3332 | 0.030 |
Why?
|
Mice | 5 | 2022 | 81209 | 0.030 |
Why?
|
Adult Children | 1 | 2014 | 103 | 0.030 |
Why?
|
Genetic Predisposition to Disease | 2 | 2008 | 17790 | 0.030 |
Why?
|
Regional Blood Flow | 1 | 2017 | 1490 | 0.030 |
Why?
|
Deuterium Exchange Measurement | 1 | 2013 | 31 | 0.030 |
Why?
|
Spectrum Analysis | 1 | 2015 | 453 | 0.030 |
Why?
|
Databases, Factual | 1 | 2008 | 8022 | 0.030 |
Why?
|
Gorilla gorilla | 1 | 2011 | 29 | 0.030 |
Why?
|
Benchmarking | 1 | 2018 | 1044 | 0.020 |
Why?
|
Leukemia L1210 | 1 | 2011 | 44 | 0.020 |
Why?
|
Elastic Modulus | 1 | 2012 | 210 | 0.020 |
Why?
|
Pathology, Molecular | 1 | 2014 | 329 | 0.020 |
Why?
|
Gestational Age | 1 | 2020 | 3564 | 0.020 |
Why?
|
Fourier Analysis | 1 | 2012 | 439 | 0.020 |
Why?
|
Clone Cells | 1 | 2014 | 1663 | 0.020 |
Why?
|
Erythrocyte Membrane | 1 | 2012 | 439 | 0.020 |
Why?
|
Myocardial Infarction | 1 | 2012 | 11890 | 0.020 |
Why?
|
Genetic Variation | 2 | 2002 | 6552 | 0.020 |
Why?
|
Diabetes, Gestational | 1 | 2020 | 1242 | 0.020 |
Why?
|
Adoptive Transfer | 1 | 2012 | 822 | 0.020 |
Why?
|
Vascular Resistance | 1 | 2012 | 933 | 0.020 |
Why?
|
Biological Transport | 1 | 2013 | 2086 | 0.020 |
Why?
|
Rhabdomyolysis | 1 | 2010 | 155 | 0.020 |
Why?
|
B-Lymphocytes | 1 | 2022 | 4742 | 0.020 |
Why?
|
Anisotropy | 1 | 2012 | 1278 | 0.020 |
Why?
|
Constriction, Pathologic | 1 | 2012 | 1098 | 0.020 |
Why?
|
Recurrence | 1 | 2020 | 8483 | 0.020 |
Why?
|
Heterozygote | 1 | 2014 | 2798 | 0.020 |
Why?
|
Medical Informatics | 1 | 2014 | 733 | 0.020 |
Why?
|
Hepatocytes | 1 | 2014 | 1229 | 0.020 |
Why?
|
Microscopy | 1 | 2012 | 885 | 0.020 |
Why?
|
Massachusetts | 1 | 2020 | 8803 | 0.020 |
Why?
|
Myeloid Cells | 1 | 2012 | 821 | 0.020 |
Why?
|
Pedigree | 1 | 2014 | 4578 | 0.020 |
Why?
|
Cell Death | 1 | 2012 | 1671 | 0.020 |
Why?
|
DNA Mutational Analysis | 1 | 2014 | 4108 | 0.020 |
Why?
|
Light | 1 | 2012 | 1344 | 0.020 |
Why?
|
Interleukin-1beta | 1 | 2012 | 999 | 0.020 |
Why?
|
Drug Synergism | 1 | 2010 | 1752 | 0.020 |
Why?
|
Insulin | 1 | 2020 | 6596 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2015 | 6544 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2020 | 14494 | 0.010 |
Why?
|
Research Design | 1 | 2019 | 6180 | 0.010 |
Why?
|
Gene Pool | 1 | 2002 | 35 | 0.010 |
Why?
|
Fibroblasts | 1 | 2013 | 4089 | 0.010 |
Why?
|
Malaria, Falciparum | 1 | 2011 | 1076 | 0.010 |
Why?
|
Saccharomyces cerevisiae | 1 | 2013 | 2698 | 0.010 |
Why?
|
Pan troglodytes | 1 | 2002 | 224 | 0.010 |
Why?
|
Glucosephosphate Dehydrogenase | 1 | 2002 | 210 | 0.010 |
Why?
|
Escherichia coli | 1 | 2013 | 4219 | 0.010 |
Why?
|
CD40 Ligand | 1 | 2002 | 521 | 0.010 |
Why?
|
Wound Healing | 1 | 2012 | 2788 | 0.010 |
Why?
|
Phenotype | 1 | 2018 | 16548 | 0.010 |
Why?
|
Africa | 1 | 2002 | 706 | 0.010 |
Why?
|
Liver | 1 | 2014 | 7510 | 0.010 |
Why?
|
Homozygote | 1 | 2002 | 1788 | 0.010 |
Why?
|
Linkage Disequilibrium | 1 | 2002 | 1996 | 0.010 |
Why?
|
Cohort Studies | 1 | 2020 | 41337 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2012 | 14374 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2023 | 64981 | 0.010 |
Why?
|
T-Lymphocytes | 1 | 2013 | 10181 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2012 | 15840 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2012 | 22020 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 2 | 2002 | 15790 | 0.010 |
Why?
|
Incidence | 1 | 2010 | 21391 | 0.010 |
Why?
|
Alleles | 1 | 2002 | 6900 | 0.010 |
Why?
|
Stroke | 1 | 2012 | 9952 | 0.010 |
Why?
|
Signal Transduction | 1 | 2012 | 23374 | 0.000 |
Why?
|
Concepts
(258)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(95)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_